Skip to main content

Home/ Cancer/ Group items tagged Therapy GM-CSF oncolytic_viruses virus viruses

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

BioVex To Announce Updated Survival Data From A Phase II Clinical Study Of OncoVEX GM-C... - 0 views

www.medicalnewstoday.com/...150301.php

2009 May medicalnewstoday news cancer metastatic melanoma phase_II trial BioVex ASCO GM-CSF oncolytic herpes virus oncolytic_virus oncolytic_viruses viruses OncoVEX experimental treatment therapy virotherapy Survival Data

shared by Matti Narkia on 24 May 09 - Cached
  • Matti Narkia on 24 May 09
     
    BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced that updated survival data from its Phase II study in metastatic melanoma will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 29, 2009 - June 2, 2009 in Orlando, F
1 - 1 of 1
Showing 20▼ items per page